» Authors » Mohammad Pakzad

Mohammad Pakzad

Explore the profile of Mohammad Pakzad including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 362
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kashani S, Navabi R, Amini A, Hajinasrollah M, Jenab Y, Rabbani S, et al.
Life Sci . 2023 Jul; 329:121950. PMID: 37473804
Aims: This study aimed to investigate the therapeutic potential of a homogenous clonal population of mesenchymal stem cells (cMSC) and their extracellular vesicles (cMSC-EV) subpopulations on isolated rat islets in...
2.
Mansouri-Kivaj N, Nazari A, Esfandiari F, Shekari F, Ghaffari M, Pakzad M, et al.
Stem Cell Res Ther . 2023 Apr; 14(1):61. PMID: 37013655
Background: Asherman syndrome (AS), or intrauterine adhesions, is a main cause of infertility in reproductive age women after endometrial injury. Mesenchymal stem cells (MSCs) and their extracellular vesicles (EVs) are...
3.
Eslami N, Bahrehbar K, Esfandiari F, Shekari F, Hassani S, Nazari A, et al.
Life Sci . 2023 Mar; 321:121536. PMID: 36868400
Aims: Some studies have shown that mesenchymal stem cells (MSCs) and their derived extracellular vesicles (MSC-EVs) can restore ovarian function in premature ovarian failure (POF), however, concerns about their efficacy...
4.
Afzal E, Pakzad M, Nouri M, Moghadasali R, Zarrabi M
Cell Tissue Bank . 2022 May; 24(1):59-66. PMID: 35635634
In the use of bovine fetal serum (FBS) there is concern about the possibility of disease transmission from animal to human. Therefore, it seems necessary to create culture conditions free...
5.
Tayebi B, Babaahmadi M, Pakzad M, Hajinasrollah M, Mostafaei F, Jahangiri S, et al.
Stem Cell Res Ther . 2022 May; 13(1):213. PMID: 35619148
Introduction: Mesenchymal stromal cells (MSCs) have opened a new window to treat inflammatory and non-inflammatory diseases. Nonetheless, their clinical applications require rigorous control and monitoring procedures to ensure full compliance...
6.
Pakzad M, Hassani S, Abbasi F, Hajizadeh-Saffar E, Taghiyar L, Fallah N, et al.
Stem Cell Rev Rep . 2022 Feb; 18(7):2279-2295. PMID: 35175538
Background: Allogeneic mesenchymal stromal cells (MSCs) have been used extensively in various clinical trials. Nevertheless, there are concerns about their efficacy, attributed mainly to the heterogeneity of the applied populations....
7.
Hassani S, Totonchi M, Sharifi-Zarchi A, Mollamohammadi S, Pakzad M, Moradi S, et al.
Stem Cell Rev Rep . 2021 Oct; 18(1):399. PMID: 34613551
No abstract available.
8.
Ghezelayagh Z, Zabihi M, Zarkesh I, Goncalves C, Larsen M, Hagh-Parast N, et al.
Stem Cell Rev Rep . 2021 Sep; 18(1):360-377. PMID: 34586606
Mesenchymal cells of diverse origins differ in gene and protein expression besides producing varying effects on their organ-matched epithelial cells' maintenance and differentiation capacity. Co-culture with rodent's tissue-specific pancreatic mesenchyme...
9.
10.
Firoozi S, Pahlavan S, Ghanian M, Rabbani S, Barekat M, Nazari A, et al.
Biochem Biophys Res Commun . 2020 Feb; 524(4):903-909. PMID: 32057366
Purpose: The aim of this study was to investigate the cardiac repair effect of human bone marrow mesenchymal stromal cells-derived extracellular vesicles (MSC-EVs) after intramyocardial injection in free form or...